MSI-L

Clinical trials for MSI-L explained in plain language.

Never miss a new study

Get alerted when new MSI-L trials appear

Sign up with your email to follow new studies for MSI-L, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New triple therapy aims to shrink hard-to-treat rectal cancers before surgery

Disease control Recruiting now

This study tests whether combining an immunotherapy drug (serplulimab) with chemotherapy (CAPEOX) and an anti-inflammatory drug (celecoxib) can shrink advanced rectal cancers before surgery. The trial enrolls 50 adults with a specific type of rectal cancer (pMMR/MSS) that usually…

Matched conditions: MSI-L

Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

MSI-L

Get alerted when new MSI-L trials appear

New triple therapy aims to shrink hard-to-treat rectal cancers before surgery